Safety evaluation of certain food additives - ipcs inchem

576 MISCELLANEOUS NITROGEN-CONTAINING SUBSTANCES (addendum)
Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B. & Zeiger, E. (1986)
Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ.
Mutagen., 8(Suppl. 7), 1–119.
Musk, S.R.R. & Johnson, I.T. (1993) The clastogenic effects of isothiocyanates. Mutat. Res.,
300, 11–117.
National Toxicology Program (1982) Carcinogenesis bioassay of allyl isothiocyanate (CAS
No. 57-06-7) in F344/N rats and B6C3F1 mice. Gavage study. Research Triangle Park,
NC, United States Department of Health and Human Services, National Institutes of Health,
National Institute of Environmental Health Sciences, National Toxicology Program
(Technical Report Series No. 234; NIH Publication No. 83-1790).
Neudecker, T. & Henschler, D. (1985) Allyl isothiocyanate is mutagenic in Salmonella
typhimurium. Mutat. Res., 156, 33–37.
Nijssen, B., van Ingen-Visscher, K. & Donders, J. (2007) VCF (Volatile Compounds in Food)
database. Zeist, Netherlands, TNO Nutrition and Food Research (http://www.vcf-online.nl/
VcfHome.cfm; Version 9.1 accessed September 2007).
Okazaki, K., Yamagishi, M., Son, H.-Y., Imazawa, T., Furukawa, F., Nakamura, H., Nishikawa,
A., Masegi, T. & Hirose, M. (2002) Simultaneous treatment with benzyl isothiocyanate, a
strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4hydroxybutyl)nitrosamine.
Nutr. Cancer, 42(2), 211–216.
Pullar, J.M., Thomson, S.J., King, M.J., Turnbull, C.I., Midwinter, R.G. & Hampton, M.B. (2004)
The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated
apoptosis. Carcinogenesis, 25(5), 765–772.
Samaha, H.S., Kelloff, G.J., Steele, V., Rao, C.V. & Reddy, B.S. (1997) Modulation of
apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl
isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and
promotion. Cancer Res., 57(7), 1301–1305.
Scott, D., Galloway, S.M., Marshall, R.R., Ishidate, M., Brusick, D., Ashby, J. & Myhr, B.C.
(1991) Genotoxicity under extreme culture conditions. A report from ICPEMC task group
9. Mutat. Res., 257(2), 147–205.
Seeberg, A.H., Mosesso, P. & Forster, R. (1988) High dose level effects in mutagenicity assays
utilizing mammalian cells in culture. Mutagenesis, 3, 213–218.
Smith, T.J., Guo, Z.Y., Thomas, P.E., Chung, F.L., Morse, M.A., Elkind, K. & Yang, C.S. (1990)
Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes
and its inhibition by isothiocyanates. Cancer Res., 50(21), 6817–6822.
Sugiura, S., Ogawa, K., Hirose, M., Takeshita, F., Asamoto, M. & Shirai, T. (2003) Reversibility
of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated
with phenylethyl isothiocyanate. Carcinogenesis, 24(3), 547–553.
Thornalley, P.J. (2002) Isothiocyanates: mechanism of cancer chemopreventive action.
Anticancer Drugs, 13(4), 331–338.
Uda, Y., Ohnuki, H. & Matsuzawa, M. (1992) Mutagenicity of volatile -alkenyl isothiocyanates
and their corresponding cyano-epithioalkanes. Biosci. Biotechnol. Biochem., 56(1),
159–160.
Xu, K. & Thornalley, P.J. (2000) Studies on the mechanism of the inhibition of human
leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro.
Biochem. Pharmacol., 60(2), 221–231.
Xu, K. & Thornalley, P.J. (2001) Signal transduction activated by the cancer chemopreventive
isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK.
Br. J. Cancer, 84(5), 670–673.
Yamaguchi, T. (1980) Mutagenicity of isothiocyanates, isocyanates and thioureas on
Salmonella typhimurium. Agric. Biol. Chem., 44(12), 3017–3018.